Back to Search
Start Over
Dietary arginine silicate inositol complex increased bone healing: histologic and histomorphometric study
- Source :
- Drug Design, Development and Therapy
- Publication Year :
- 2016
- Publisher :
- Informa UK Limited, 2016.
-
Abstract
- Ferhan Yaman,1 Izzet Acikan,1 Serkan Dundar,2 Sercan Simsek,3 Mehmet Gul,4 Ä°brahim Hanifi Ozercan,3 James Komorowski,5 Kazim Sahin6 1Department of Oral-Maxillofacial Surgery, Faculty of Dentistry, Dicle University, Diyarbakir, Turkey; 2Department of Periodontology, Faculty of Dentistry, Firat University, Elazig, Turkey; 3Department of Pathology, Faculty of Medicine, Firat University, Elazig, Turkey; 4Department of Periodontology, Faculty of Dentistry, Dicle University, Diyarbakir, Turkey; 5Nutrition 21, LLC, Purchase, NY, USA; 6Department of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig, Turkey Background: Arginine silicate inositol complex (ASI; arginine 49.5%, silicon 8.2%, and inositol 25%) is a novel material that is a bioavailable source of silicon and arginine. ASI offers potential benefits for vascular and bone health. Objective: The aim of this study was to evaluate the potential effects of ASI complex on bone healing of critical-sized defects in rats. Methods: The rats were randomly assigned to two groups of 21 rats each. The control group was fed a standard diet for 12 weeks; after the first 8 weeks, a calvarial critical-sized defect was created, and the rats were sacrificed 7, 14, and 28 days later. The ASI group was fed a dietcontaining 1.81 g/kg of ASI for 12 weeks; after the first 8 weeks, a calvarial critical-sized defect was created, and the rats were sacrificed 7, 14, and 28 days later. The calvarial bones of all the rats were then harvested for evaluation. Results: Osteoblasts and osteoclasts were detected at higher levels in the ASI group compared with the control group at days 7, 14, and 28 of the calvarial defect (P0.05). Conclusion: ASI supplementation significantly improved bone tissue healing in rats with critical-sized defects. This study demonstrated that ASI can enhance bone repair and has potential as a therapeutic regimen in humans. Keywords: arginine silicate inositol, bone healing, osteoblast, osteoclast, critical-sized defect
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Bone Regeneration
Arginine
Osteoclasts
Pharmaceutical Science
Bone healing
Rats, Sprague-Dawley
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
critical-sized defect
Osteoclast
Internal medicine
mental disorders
Drug Discovery
medicine
Animals
Inositol
Bone regeneration
Original Research
Pharmacology
Wound Healing
Drug Design, Development and Therapy
Osteoblasts
Silicates
technology, industry, and agriculture
Osteoblast
030206 dentistry
Rats
Bioavailability
arginine silicate inositol
030104 developmental biology
Endocrinology
medicine.anatomical_structure
chemistry
osteoclast
Dietary Supplements
osteoblast
Female
bone healing
Wound healing
Subjects
Details
- ISSN :
- 11778881
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- Drug Design, Development and Therapy
- Accession number :
- edsair.doi.dedup.....4015121a23f684fe1ba28a63b039cf53
- Full Text :
- https://doi.org/10.2147/dddt.s109271